Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Tissue tropism and target cells of NSs-deleted rift valley fever virus in live immunodeficient mice.

Gommet C, Billecocq A, Jouvion G, Hasan M, Zaverucha do Valle T, Guillemot L, Blanchet C, van Rooijen N, Montagutelli X, Bouloy M, Panthier JJ.

PLoS Negl Trop Dis. 2011 Dec;5(12):e1421. doi: 10.1371/journal.pntd.0001421. Epub 2011 Dec 6.

2.

Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation.

Ikegami T, Narayanan K, Won S, Kamitani W, Peters CJ, Makino S.

PLoS Pathog. 2009 Feb;5(2):e1000287. doi: 10.1371/journal.ppat.1000287. Epub 2009 Feb 6.

3.

Nonstructural NSs protein of rift valley fever virus interacts with pericentromeric DNA sequences of the host cell, inducing chromosome cohesion and segregation defects.

Mansuroglu Z, Josse T, Gilleron J, Billecocq A, Leger P, Bouloy M, Bonnefoy E.

J Virol. 2010 Jan;84(2):928-39. doi: 10.1128/JVI.01165-09. Epub 2009 Nov 4.

4.

Aedes mosquito saliva modulates Rift Valley fever virus pathogenicity.

Le Coupanec A, Babin D, Fiette L, Jouvion G, Ave P, Misse D, Bouloy M, Choumet V.

PLoS Negl Trop Dis. 2013 Jun 13;7(6):e2237. doi: 10.1371/journal.pntd.0002237. Print 2013.

5.

Post-exposure vaccination with MP-12 lacking NSs protects mice against lethal Rift Valley fever virus challenge.

Gowen BB, Bailey KW, Scharton D, Vest Z, Westover JB, Skirpstunas R, Ikegami T.

Antiviral Res. 2013 May;98(2):135-43. doi: 10.1016/j.antiviral.2013.03.009. Epub 2013 Mar 21.

6.

Rift Valley fever virus clearance and protection from neurologic disease are dependent on CD4+ T cell and virus-specific antibody responses.

Dodd KA, McElroy AK, Jones ME, Nichol ST, Spiropoulou CF.

J Virol. 2013 Jun;87(11):6161-71. doi: 10.1128/JVI.00337-13. Epub 2013 Mar 27.

7.

Mechanistic Insight into the Host Transcription Inhibition Function of Rift Valley Fever Virus NSs and Its Importance in Virulence.

Terasaki K, Ramirez SI, Makino S.

PLoS Negl Trop Dis. 2016 Oct 6;10(10):e0005047. doi: 10.1371/journal.pntd.0005047. eCollection 2016 Oct.

8.

Rift valley Fever virus encephalitis is associated with an ineffective systemic immune response and activated T cell infiltration into the CNS in an immunocompetent mouse model.

Dodd KA, McElroy AK, Jones TL, Zaki SR, Nichol ST, Spiropoulou CF.

PLoS Negl Trop Dis. 2014 Jun 12;8(6):e2874. doi: 10.1371/journal.pntd.0002874. eCollection 2014 Jun.

9.

Creation of Rift Valley fever viruses with four-segmented genomes reveals flexibility in bunyavirus genome packaging.

Wichgers Schreur PJ, Oreshkova N, Moormann RJ, Kortekaas J.

J Virol. 2014 Sep;88(18):10883-93. doi: 10.1128/JVI.00961-14. Epub 2014 Jul 9.

10.

Choice of inbred rat strain impacts lethality and disease course after respiratory infection with Rift Valley Fever Virus.

Bales JM, Powell DS, Bethel LM, Reed DS, Hartman AL.

Front Cell Infect Microbiol. 2012 Aug 2;2:105. doi: 10.3389/fcimb.2012.00105. eCollection 2012.

11.

Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment.

Scharton D, Bailey KW, Vest Z, Westover JB, Kumaki Y, Van Wettere A, Furuta Y, Gowen BB.

Antiviral Res. 2014 Apr;104:84-92. doi: 10.1016/j.antiviral.2014.01.016. Epub 2014 Jan 31.

12.

Infection and transmission of Rift Valley fever viruses lacking the NSs and/or NSm genes in mosquitoes: potential role for NSm in mosquito infection.

Crabtree MB, Kent Crockett RJ, Bird BH, Nichol ST, Erickson BR, Biggerstaff BJ, Horiuchi K, Miller BR.

PLoS Negl Trop Dis. 2012;6(5):e1639. doi: 10.1371/journal.pntd.0001639. Epub 2012 May 1.

13.

The pathogenesis of Rift Valley fever virus in the mouse model.

Smith DR, Steele KE, Shamblin J, Honko A, Johnson J, Reed C, Kennedy M, Chapman JL, Hensley LE.

Virology. 2010 Nov 25;407(2):256-67. doi: 10.1016/j.virol.2010.08.016. Epub 2010 Sep 17.

15.

Nuclear relocalization of polyadenylate binding protein during rift valley fever virus infection involves expression of the NSs gene.

Copeland AM, Altamura LA, Van Deusen NM, Schmaljohn CS.

J Virol. 2013 Nov;87(21):11659-69. doi: 10.1128/JVI.01434-13. Epub 2013 Aug 21.

16.

Chemotactic and inflammatory responses in the liver and brain are associated with pathogenesis of Rift Valley fever virus infection in the mouse.

Gray KK, Worthy MN, Juelich TL, Agar SL, Poussard A, Ragland D, Freiberg AN, Holbrook MR.

PLoS Negl Trop Dis. 2012;6(2):e1529. doi: 10.1371/journal.pntd.0001529. Epub 2012 Feb 28.

17.

Reactive oxygen species activate NFκB (p65) and p53 and induce apoptosis in RVFV infected liver cells.

Narayanan A, Amaya M, Voss K, Chung M, Benedict A, Sampey G, Kehn-Hall K, Luchini A, Liotta L, Bailey C, Kumar A, Bavari S, Hakami RM, Kashanchi F.

Virology. 2014 Jan 20;449:270-86. doi: 10.1016/j.virol.2013.11.023. Epub 2013 Dec 15.

18.

The role of signal transducer and activator of transcription 3 in Rift Valley fever virus infection.

Pinkham C, An S, Lundberg L, Bansal N, Benedict A, Narayanan A, Kehn-Hall K.

Virology. 2016 Sep;496:175-185. doi: 10.1016/j.virol.2016.06.004. Epub 2016 Jun 16.

19.

[Study on DNA immune of envelope protein gene of Rift Valley Fever Virus].

Wang QH, Wang XJ, Hu S, Ge JY, Bu ZG.

Wei Sheng Wu Xue Bao. 2007 Aug;47(4):677-81. Chinese.

PMID:
17944371
20.

Inactivation of infectious virus and serological detection of virus antigen in Rift Valley fever virus-exposed mosquitoes fixed with paraformaldehyde.

Kading R, Crabtree M, Miller B.

J Virol Methods. 2013 Apr;189(1):184-8. doi: 10.1016/j.jviromet.2013.01.014. Epub 2013 Feb 4.

PMID:
23391826

Supplemental Content

Support Center